-
Thematic Analysis
FDI Trends in APAC (2025)
Overall, the Asia-Pacific (APAC) region experienced significant growth in inward Foreign Direct Investment (FDI) for 2024. This growth was primarily focused on sectors such as renewables, communications/media, and electronics, with the United States, United Kingdom, and France identified as major investors. In 2025, increasing trade barriers and geopolitical tensions are altering the landscape of APAC FDI. While protectionist measures and security-driven screening are redirecting some investments, such as semiconductors from Taiwan, towards the United States, resilient markets like India and...
-
Sector Analysis
Bio/Pharmaceutical Outsourcing Report, October 2025
The Bio/Pharmaceutical Outsourcing Report is a monthly analysis of news and trends affecting pharmaceutical Contract Manufacturing Organizations (CMOs). It includes in-depth analyses of the latest business conditions, lists new outsourcing contracts, assesses the latest opportunities and threats for manufacturers, and identifies recent mergers, acquisitions, and financing among CMOs. It also updates readers on facility-level news, such as planned site openings and closures, Good Manufacturing Practice (GMP) inspections, and investments in technology and equipment.
-
Product Insights
Metabolic Dysfunction-Associated Steatohepatitis (MASH or NASH): Global Clinical Trials Review, 2025
GlobalData's clinical trial report, “Metabolic Dysfunction-Associated Steatohepatitis (MASH or NASH) - Global Clinical Trials Review, 2025" provides an overview of Metabolic Dysfunction-Associated Steatohepatitis (MASH or NASH) Clinical trials scenario. This report provides top line data relating to the clinical trials on Metabolic Dysfunction-Associated Steatohepatitis (MASH or NASH). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase,...
-
Product Insights
Reflux Esophagitis (Gastroesophageal Reflux Disease): Global Clinical Trials Review, 2025
GlobalData's clinical trial report, “Reflux Esophagitis (Gastroesophageal Reflux Disease) - Global Clinical Trials Review, 2025" provides an overview of Reflux Esophagitis (Gastroesophageal Reflux Disease) Clinical trials scenario. This report provides top line data relating to the clinical trials on Reflux Esophagitis (Gastroesophageal Reflux Disease). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end...
-
Product Insights
IgA Nephropathy (Berger's Disease): Global Clinical Trials Review, 2025
GlobalData's clinical trial report, “IgA Nephropathy (Berger's Disease) - Global Clinical Trials Review, 2025" provides an overview of IgA Nephropathy (Berger's Disease) Clinical trials scenario. This report provides top line data relating to the clinical trials on IgA Nephropathy (Berger's Disease). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Malnutrition: Global Clinical Trials Review, 2025
GlobalData's clinical trial report, “Malnutrition - Global Clinical Trials Review, 2025" provides an overview of Malnutrition Clinical trials scenario. This report provides top line data relating to the clinical trials on Malnutrition. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Lupus Nephritis: Global Clinical Trials Review, 2025
GlobalData's clinical trial report, “Lupus Nephritis - Global Clinical Trials Review, 2025" provides an overview of Lupus Nephritis Clinical trials scenario. This report provides top line data relating to the clinical trials on Lupus Nephritis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Monkeypox: Global Clinical Trials Review, 2025
GlobalData's clinical trial report, “Monkeypox - Global Clinical Trials Review, 2025" provides an overview of Monkeypox Clinical trials scenario. This report provides top line data relating to the clinical trials on Monkeypox. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Cytopenia: Global Clinical Trials Review, 2025
GlobalData's clinical trial report, “Cytopenia - Global Clinical Trials Review, 2025" provides an overview of Cytopenia Clinical trials scenario. This report provides top line data relating to the clinical trials on Cytopenia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Sector Analysis
Confronting the Chikungunya Threat
Chikungunya is a disease caused by the chikungunya virus (CHIKV), which is spread to humans by Aedes aegypti or Aedes albopictus mosquitoes. The disease has become increasingly prevalent since the beginning of 2025, reaching into areas beyond its traditional geographical base to the extent that it has been earmarked as having the potential to be the next pandemic. In this strategic report, GlobalData traces the recent spread of the virus, examines vaccines and other measures that are being used to combat the disease, and...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.